Asa and Everolimus drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Asa (aspirin) and Everolimus (everolimus). Common drug interactions include musculoskeletal pain among females and pneumonia among males.

The phase IV clinical study analyzes what interactions people have when they take Asa and Everolimus. It is created by eHealthMe based on reports of 20 people who take the same drugs from the FDA, and is updated regularly.

What is Asa?

Asa has active ingredients of aspirin. It is often used in blood clots. eHealthMe is studying from 32,557 Asa users. Check the latest studies of Asa.

What is Everolimus?

Everolimus has active ingredients of everolimus. eHealthMe is studying from 16,228 Everolimus users. Check the latest studies of Everolimus.



On Jul, 26, 2026

20 people who take Asa and Everolimus together, and have interactions are studied.

Asa and Everolimus drug interactions.

What are the common drug interactions of Asa and Everolimus, by gender? *:

female:

  1. Musculoskeletal pain (pain affects the bones, muscles, ligaments, tendons, and nerves)
  2. Myalgia (muscle pain)
  3. Nasal congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels)
  4. Nausea (feeling of having an urge to vomit)
  5. Nervousness
  6. Oedema peripheral (superficial swelling)
  7. Oral herpes (viral infection of mouth)
  8. Oropharyngeal pain
  9. Pneumonia
  10. Psoriasis (immune-mediated disease that affects the skin)

male:

  1. Pneumonia
  2. Anaemia (lack of blood)
  3. Myoclonus (a brief, involuntary twitching of a muscle or a group of muscles)
  4. Posterior reversible encephalopathy syndrome (posterior reversible encephalopathy syndrome (pres), also known as reversible posterior leukoencephalopathy syndrome (rpls), is a syndrome characterized by headache, confusion, seizures and visual loss)
  5. Renal impairment (severely reduced kidney function)
  6. Alveolitis (inflammation in the socket of a tooth)
  7. Amnestic disorder (group of disorders that involve loss of memories previously established, loss of the ability to create new memories)
  8. Aortic valve calcification
  9. Aortic valve disease
  10. Aortic valve sclerosis (narrowing of the aortic valve)

What are the common drug interactions of Asa and Everolimus, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Anaemia (lack of blood)
  2. Blood creatinine increased
  3. Blood lactate dehydrogenase increased
  4. Grand mal convulsion (a type of generalized seizure that affects the entire brain)
  5. Hemiparesis (weakness on one side of the body)
  6. Ischaemic stroke (stroke; caused by an interruption in the flow of blood to the brain)
  7. Myoclonus (a brief, involuntary twitching of a muscle or a group of muscles)
  8. Posterior reversible encephalopathy syndrome (posterior reversible encephalopathy syndrome (pres), also known as reversible posterior leukoencephalopathy syndrome (rpls), is a syndrome characterized by headache, confusion, seizures and visual loss)
  9. Renal impairment (severely reduced kidney function)
  10. Asthenia (weakness)

50-59:

  1. Anaemia (lack of blood)
  2. Asthenia (weakness)
  3. Fluid retention (an abnormal accumulation of fluid in the blood)
  4. Hallucination (an experience involving the perception of something not present)
  5. Kidney transplant rejection
  6. Lethargy (tiredness)
  7. Lung disorder (lung disease)
  8. Meniere's disease (a disorder of the inner ear that can affect hearing and balance to a varying degree)
  9. Peripheral swelling
  10. Secondary immunodeficiency (lack of immunity due to some disease)

60+:

  1. Pneumonia
  2. Liver transplant rejection (failure of liver transplant)
  3. Bone disorder
  4. Cardiac failure
  5. Cardiac failure congestive
  6. Cyanosis (lack of oxygen in body leads to blue appearance of skin ,mucous membrane nails)
  7. Diastolic dysfunction
  8. Dyspnoea (difficult or laboured respiration)
  9. Dyspnoea at rest (difficult or laboured breathing during rest)
  10. Dyspnoea exertional (breathlessness or shortness of breath)

What are the existing conditions these people have? *

  1. Renal Cell Carcinoma (a kidney cancer): 6 people, 30.00%
  2. Heart Disease: 3 people, 15.00%
  3. Carcinoid Tumor: 2 people, 10.00%
  4. Coronary Heart Disease (narrowing or blockage of the coronary arteries): 2 people, 10.00%
  5. Heart Attack: 1 person, 5.00%
  6. Depression: 1 person, 5.00%
  7. Diabetic Nephropathy (diabetic kidney disease): 1 person, 5.00%
  8. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 5.00%
  9. Hair Loss: 1 person, 5.00%
  10. Type 2 Diabetes: 1 person, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Asa and Everolimus?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Asa and Everolimus:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Asa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Everolimus:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Asa and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Everolimus and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on aspirin and everolimus (the active ingredients of Asa and Everolimus, respectively), and Asa and Everolimus (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: